4.4 Review

Models of care for adolescent and young adult cancer programs

Journal

PEDIATRIC BLOOD & CANCER
Volume 66, Issue 12, Pages -

Publisher

WILEY
DOI: 10.1002/pbc.27991

Keywords

adolescents and young adults; clinical care; models of care

Ask authors/readers for more resources

This review draws on the experience of adolescent and young adult (AYA) cancer clinicians from Australia, the United States, and the United Kingdom to summarize common aspects of models of care implemented in their countries. The principles underpinning these models include patient- and family-focused care informed by an understanding of normal AYA development, enhancing existing adult or pediatric cancer services to meet the needs of AYA, and promoting collaboration between pediatric and adult oncologists. Common elements of AYA cancer care include establishing an AYA multidisciplinary team that integrates medical and psychosocial care, efforts to centralize complex care, providing access and equity for all AYA, promoting clinical trials, and helping facilitate transition to healthy survivorship. Several organizational approaches are described, noting that local program development depends on resources, infrastructure, and assessment of unmet needs within the region. The development of national networks provides opportunities for shared learning and approaches to evaluation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Breast cancer in adolescents and young adults

Rebecca H. Johnson, Carey K. Anders, Jennifer K. Litton, Kathryn J. Ruddy, Archie Bleyer

PEDIATRIC BLOOD & CANCER (2018)

Article Oncology

A randomized controlled trial of a structured exercise intervention after the completion of acute cancer treatment in adolescents and young adults

Morgan Atkinson, Andrew Murnane, Thomas Goddard, Cathy Pendergrast, Paul Rogers, Rebecca Manudhane, Michael Osborn

Summary: This study aimed to investigate the effects of a structured 10-week exercise intervention on cardiorespiratory fitness, fatigue, and quality of life in adolescents and young adults who have recently completed cancer treatment. The exercise group showed significant improvement in VO2peak at 10 weeks compared to controls, with no significant differences in fatigue or total quality of life scores between groups. The plateau in VO2peak at six months suggests the potential benefit of a maintenance exercise program.

PEDIATRIC BLOOD & CANCER (2021)

Article Oncology

The Australian Youth Cancer Service: Developing and Monitoring the Activity of Nationally Coordinated Adolescent and Young Adult Cancer Care

Pandora Patterson, Kimberley R. Allison, Helen Bibby, Kate Thompson, Jeremy Lewin, Taia Briggs, Rick Walker, Michael Osborn, Meg Plaster, Allan Hayward, Roslyn Henney, Shannyn George, Dominic Keuskamp, Antoinette Anazodo

Summary: Adolescents and young adults diagnosed with cancer face unique medical and psychosocial challenges, which require tailored and comprehensive care. The Australian Youth Cancer Services have been providing developmentally appropriate care since 2011, focusing on clinical trial participation, oncofertility, psychosocial care, and survivorship. National data collection and monitoring have facilitated improvements in the coordination and accountability of quality youth cancer care.

CANCERS (2021)

Review Oncology

Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years

Elizabeth J. Cathcart-Rake, Kathryn J. Ruddy, Archie Bleyer, Rebecca H. Johnson

Summary: The incidence of invasive breast cancer has increased among women under 42 in the United States, leading to more aggressive subtypes and advanced disease challenges. Early genetic testing and multidisciplinary treatment including chemotherapy with adjunctive ovarian function suppression and personalized cancer therapy are crucial for improving patient survival.

JCO ONCOLOGY PRACTICE (2021)

Article Oncology

Care Experience, by Site of Care, for Adolescents and Young Adults With Cancer

Rebecca L. Jacobsen, Catherine Fiona Macpherson, Bethann Mangel Pflugeisen, Rebecca H. Johnson

Summary: The study found that AYAs treated at academic centers are more likely to be offered clinical trials and be aware of supportive services, while those treated at academic centers are more satisfied with support, communication, and overall treatment. Respondents treated at academic centers were more likely to receive information relevant to their age group and reported higher overall satisfaction with their healthcare team's knowledge of AYAs.

JCO ONCOLOGY PRACTICE (2021)

Review Hematology

B-cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification

David T. O. Yeung, Michael P. Osborn, Deborah L. White

Summary: This review summarizes the genomic pathology of B-ALL at diagnosis, including mutations detectable by traditional methods and advanced molecular techniques. These studies not only help with prognosis and diagnosis, but also provide opportunities for targeted therapies.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Oncology

Long-term health-related quality of life in young childhood cancer survivors and their parents

Joanna E. Fardell, Claire E. Wakefield, Richard De Abreu Lourenco, Christina Signorelli, Maria McCarthy, Jordana McLoone, Michael Osborn, Melissa Gabriel, Antoinette Anazodo, Frank Alvaro, Liane Lockwood, Thomas Walwyn, Jane Skeen, Ramon Tillemans, Richard J. Cohn

Summary: This study investigates the HRQoL of young childhood cancer survivors and their parents, finding that parents report lower HRQoL for their children compared to population norms. Factors influencing child HRQoL include late effects and non-surgical treatments. While parents' average HRQoL is high, a subset report clinically meaningful differences from perfect health, with more anxiety/depression issues than the general population.

PEDIATRIC BLOOD & CANCER (2021)

Article Oncology

Patterns and Predictors of Healthcare Use among Adolescent and Young Adult Cancer Survivors versus a Community Comparison Group

Ursula M. Sansom-Daly, Claire E. Wakefield, Christina Signorelli, Mark W. Donoghoe, Antoinette Anazodo, Susan M. Sawyer, Michael Osborn, Rosalie Viney, Nicholas Daniell, Kate Faasse, Richard J. Cohn

Summary: Adolescent and young adult cancer survivors face significant physical/mental health late effects following cancer treatment, which can be minimized through tailored healthcare use. A cross-sectional study found that cancer survivors reported greater use of medical and mental health services, particularly females, those diagnosed with brain/solid tumors, and those more recently finished treatment. Further research is needed to determine if the healthcare accessed by these survivors is appropriate and meets their needs.

CANCERS (2021)

Article Hematology

An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL

Matthew Greenwood, Toby Trahair, Rosemary Sutton, Michael Osborn, John Kwan, Sally Mapp, Rebecca Howman, Antoinette Anazodo, Brenton Wylie, James D'Rozario, Mark Hertzberg, Ian Irving, David Yeung, Luke Coyle, Amanda Jager, Dan Engeler, Nicola Venn, Chris Frampton, Andrew H. Wei, Kenneth Bradstock, Luciano Dalla-Pozza

Summary: The ALL06 study aimed to evaluate if patients aged 15 to 39 could receive pediatric ALL regimen. The results showed that this therapy was safe and feasible in AYA patients, with similar ability to complete induction/consolidation therapy as children. The study revealed that BMI >30 kg/m(2) and day 79 MRD positivity were associated with poorer disease-free survival and overall survival rates.

BLOOD ADVANCES (2021)

Article Oncology

Case Report: Precision Medicine Target Revealed by In Vitro Modeling of Relapsed, Refractory Acute Lymphoblastic Leukemia From a Child With Neurofibromatosis

Susan L. Heatley, Elyse C. Page, Laura N. Eadie, Barbara J. McClure, Jacqueline Rehn, David T. Yeung, Michael Osborn, Tamas Revesz, Maria Kirby, Deborah L. White

Summary: Children with neurofibromatosis are at higher risk of developing certain types of leukemia, but rarely develop B-cell acute lymphoblastic leukemia (B-ALL). A study identified a new mutation in a relapsed/refractory Ph-like B-ALL patient with neurofibromatosis, which resulted in cytokine independence and increased RAS signaling, indicating leukemic transformation. Furthermore, these cells showed sensitivity to MEK inhibitors. The findings suggest a potential precision medicine target for neurofibromatosis patients with B-ALL.

FRONTIERS IN ONCOLOGY (2022)

Article Psychology, Multidisciplinary

The Clinical Utility of the Adolescent and Young Adult Psycho-Oncology Screening Tool (AYA-POST): Perspectives of AYA Cancer Patients and Healthcare Professionals

Pandora Patterson, Fiona E. J. McDonald, Kimberley R. Allison, Helen Bibby, Michael Osborn, Karen Matthews, Ursula M. Sansom-Daly, Kate Thompson, Meg Plaster, Antoinette Anazodo

Summary: The study demonstrates that the AYA-POST is a suitable tool for psychosocial screening of AYAs with cancer, facilitating the identification of distress and unique concerns in this population and valuable in triaging and tailoring care for young cancer patients. Participants' responses show high levels of satisfaction with the tool, indicating its appropriateness, practicability, and acceptability, as well as its role in facilitating communication about psychosocial needs and prompt referrals. Ratings of clinical utility did not differ significantly between AYA and HCP groups, suggesting consistency in perceptions of the tool's effectiveness across different stakeholders.

FRONTIERS IN PSYCHOLOGY (2022)

Article Genetics & Heredity

Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A-Rearranged Acute Lymphoblastic Leukemia

Laura N. Eadie, Jacqueline A. Rehn, James Breen, Michael P. Osborn, Sophie Jessop, Charlotte E. J. Downes, Susan L. Heatley, Barbara J. McClure, David T. Yeung, Tamas Revesz, Benjamin Saxon, Deborah L. White

Summary: Chromosomal rearrangements involving the KMT2A gene are common in acute lymphoblastic leukemia (ALL), particularly in infants less than 1 year old. KMT2A-rearranged ALL (KMT2Ar ALL) has a poor prognosis and often co-occurs with other chromosomal abnormalities, including disruption of the IKZF1 gene. This study reports a case of aggressive infant KMT2Ar ALL with rare IKZF1 gene fusions, and highlights the genomic complexity of this disease with the identification of novel gene fusions IKZF1::TUT1 and KDM2A::IKZF1.

GENES (2023)

Article Oncology

Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study

Jacob J. Henderson, Anirban Das, Daniel A. Morgenstern, Sumedha Sudhaman, Vanessa Bianchi, Jill Chung, Logine Negm, Melissa Edwards, David E. Kram, Michael Osborn, Cynthia Hawkins, Eric Bouffet, Yoon-Jae Cho, Uri Tabori

JCO PRECISION ONCOLOGY (2022)

No Data Available